Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -159.24% is in line with its 5-year average of -153.68%, around the middle of its 5-year range (-362.14%–-19.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.57% above its 12-month average of -200.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -159.24%.
RETURN ON INVESTED CAPITAL (ROIC)
-159.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-200.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-212.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-153.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+20.57%
CURRENT VS 3Y AVG
+24.99%
CURRENT VS 5Y AVG
-3.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.18%
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
-394.85%
vs the sector median at left
Gain Therapeutics, Inc.
Market Cap
$73.58M
Return on Invested Capital (ROIC)
-159.24%
TTM Avg
-200.49%
3Y Avg
-212.30%
5Y Avg
-153.68%
Market Cap
$72.60M
Return on Invested Capital (ROIC)
-153.46%
TTM Avg
-63.13%
3Y Avg
-47.00%
5Y Avg
-35.71%
Market Cap
$76.80M
Return on Invested Capital (ROIC)
-62.98%
TTM Avg
-85.67%
3Y Avg
-71.66%
5Y Avg
-59.37%
Market Cap
$70.09M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-72.23%
3Y Avg
-74.75%
5Y Avg
-58.95%
Market Cap
$69.33M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
20.47%
3Y Avg
-36.30%
5Y Avg
-23.36%
Market Cap
$68.78M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$68.27M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$67.63M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$80.76M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $73.58M | -159.24% | -200.49% | -212.30% | -153.68% |
| MindWalk Holdings Corp. (HYFT)vs › | $72.60M | -153.46% | -63.13% | -47.00% | -35.71% |
| Hyperfine, Inc. (HYPR)vs › | $76.80M | -62.98% | -85.67% | -71.66% | -59.37% |
| iBio, Inc. (IBIO)vs › | $70.09M | -40.22% | -72.23% | -74.75% | -58.95% |
| Champions Oncology, Inc. (CSBR)vs › | $69.33M | -6.75% | 20.47% | -36.30% | -23.36% |
| PDS Biotechnology Corporation (PDSB)vs › | $68.78M | -3699.99% | -104.88% | -89.50% | -74.29% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.27M | -10.85% | -101.00% | -120.85% | -96.47% |
| Heron Therapeutics, Inc. (HRTX)vs › | $67.63M | -6.79% | -4.87% | -47.70% | -62.00% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $80.76M | -836.58% | -213.85% | -158.30% | -121.35% |
| Pulmonx Corporation (LUNG)vs › | $81.31M | -48.39% | -44.64% | -40.56% | -32.79% |
ROIC
-159.2%
ROE
-178.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -159.24% |
| 2026-03-31 | -131.72% |
| 2025-12-31 | -95.62% |
| 2025-09-30 | -253.74% |
| 2025-06-30 | -362.14% |
| 2025-03-31 | -303.22% |
| 2024-12-31 | -244.52% |
| 2024-09-30 | -216.67% |
| 2024-06-30 | -170.93% |
| 2024-03-31 | -221.00% |
| 2023-12-31 | -161.51% |
| 2023-09-30 | -265.38% |
| 2023-06-30 | -174.22% |
| 2023-03-31 | -121.14% |
| 2022-12-31 | -88.52% |
| 2022-09-30 | -68.17% |
| 2022-06-30 | -57.10% |
| 2022-03-31 | -43.77% |
| 2021-12-31 | -37.84% |
| 2021-09-30 | -31.31% |
| 2021-06-30 | -19.59% |
| 2021-03-31 | -11.88% |
| 2020-12-31 | -46.32% |
| 2020-09-30 | -29.24% |
